Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
α-Synuclein (asyn) is a key pathogenetic factor in a group of neurodegenerative diseases generically known as synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Although the initial triggers of pathology and progression are uncle...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2022-05-01
|
| Sarja: | Frontiers in Neurology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fneur.2022.852003/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|